CPS-071 - Impact of the introduction of Generic Apixaban and Rivaroxaban: Case-study of a pharmacy in a suburban area of Lisbon, Portugal

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: CPS-071
• By: LOURENçO, Luís (CPG - Central Pharma Group, Portugal)
• Co-author(s): Luís Lourenço (CPG - Central Pharma Group, Lisboa, Portugal)
  José Pais
  Pedro Silva
  Catarina Teodósio
  Marta Lopes
  Abdelhak Lemsaddek
  
• Abstract:

  Introduction
  The introduction of generic drugs into the pharmaceutical market has a significant impact on the sales of brand-name medications. Generics are more affordable versions of original drugs, containing the same active substance, dosage, and pharmaceutical form, being commercialized after the expiration of the reference drug’s patent...

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login